Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits

scientific article published on 01 January 2019

Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3233/THC-199015
P932PMC publication ID6597966
P698PubMed publication ID31045535

P2093author name stringChin-Fu Chen
Chao-Chien Hu
Hsia-Wei Liu
Jen-Ray Chaw
Yin-Chen Chiu
P2860cites workRanibizumab and bevacizumab for neovascular age-related macular degenerationQ24616209
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year resultsQ24633874
Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogelsQ30986623
Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cellsQ30990451
Multiple laser treatments for macular edema attributable to branch retinal vein occlusionQ33213626
Thermo-responsive chitosan-graft-poly(N-isopropylacrylamide) injectable hydrogel for cultivation of chondrocytes and meniscus cells.Q51100401
Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing.Q51182085
Controlled release bevacizumab in thermoresponsive hydrogel found to inhibit angiogenesis.Q53444034
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.Q53599948
Diabetic retinopathyQ75217418
Pharmacokinetics of intravitreal bevacizumab (Avastin)Q80235081
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1Q80553646
Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation.Q33308452
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsQ34047111
Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering.Q38199837
Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogelQ39432443
PEGDA hydrogels with patterned elasticity: Novel tools for the study of cell response to substrate rigidityQ39789474
Hydrophobically modified biodegradable poly(ethylene glycol) copolymers that form temperature-responsive NanogelsQ43286422
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical studyQ46528410
Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.Q46859579
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issueS1
P921main subjectangiogenesisQ539568
hydrogelQ898925
drug deliveryQ1392806
P304page(s)153-163
P577publication date2019-01-01
P1433published inTechnology and Health CareQ22030355
P1476titleThermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits
P478volume27

Search more.